Oryzon Genomics has announced the publication of a study in Frontiers in Psychiatry, which explores the potential of vafidemstat in Phelan-McDermid Syndrome (PMS). PMS is a form of autism whereby agitation and aggression (A/A) are key traits. It is therefore logical to consider vafidemstat in this patient ...Den vollständigen Artikel lesen ...
© 2025 Edison Investment Research